What is NDC 62484-1020?

62484-1020 is the product NDC for Mercaptopurine, Mercaptopurine 20 mg/mL suspension, listed with the FDA by Nova Laboratories, Ltd. It has 1 package NDC, shown above in 10- and 11-digit form.

Nova Laboratories, Ltd, NDC labeler code 62484. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mercaptopurine?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mercaptopurine NDC 62484-1020 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62484-1020Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62484-1020Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62484-1020-4	6248410200462484102004	1 BOTTLE in 1 CARTON (62484-1020-4) / 100 mL in 1 BOTTLE (62484-1020-3)Marketed from Sep 8, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mercaptopurine
Generic name (nonproprietary): mercaptopurine
Active ingredients: Mercaptopurine — 20 mg/mL
Dosage form: Suspension
Route: Oral
Labeler: Nova Laboratories, LtdNDC labeler code 62484
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 205919
Marketing start: Sep 8, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Nucleic Acid Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 62484-1020_e8f4fd0d-a6b3-4c9c-bf62-78bdb81c703dSPL ID e8f4fd0d-a6b3-4c9c-bf62-78bdb81c703dSPL set ID 9c6fc66b-522f-499d-961a-cde6ca0ec2e5RxCUI 1536484UNII E7WED276I5UPC 0362484102039
Pharmacologic class: Nucleoside Metabolic Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462484102004 followed by a unit qualifier and the quantity

Package 62484-1020-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 20, 2026.

Indications (excerpt from the label)

MERCAPTOPURINE is a nucleoside metabolic inhibitor indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. ( 1.1 ) 1.1 Acute Lymphoblastic Leukemia MERCAPTOPURINE is indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62484-1020

What is NDC 62484-1020?: 62484-1020 is the product NDC for Mercaptopurine, Mercaptopurine 20 mg/mL suspension, listed with the FDA by Nova Laboratories, Ltd. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mercaptopurine.
What is the active ingredient?: Mercaptopurine.
Who is the labeler?: Nova Laboratories, Ltd, NDC labeler code 62484. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mercaptopurine?: 5 other product NDCs are listed under this name. See all Mercaptopurine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Mercaptopurine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Mercaptopurine	Mercaptopurine 50 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-150	71921-0150-0271921-0150-25
Mercaptopurine	Mercaptopurine 20 mg/mL	SuspensionOral	Hikma Pharmaceuticals USA Inc.	0054-0879	00054-0879-49
Mercaptopurine	Mercaptopurine 20 mg/mL	SuspensionOral	Hikma Pharmaceuticals USA Inc.	0054-4582	00054-4582-49
Mercaptopurine	Mercaptopurine 50 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-4581	00054-4581-1100054-4581-27
Mercaptopurine	Mercaptopurine 50 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-983	51407-0983-25

Other NDCs under NDA 205919

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 205919
Product	Strength	Form · route	Labeler	Product NDC
Purixan	Mercaptopurine 20 mg/mL	SuspensionOral	Nova Laboratories, Ltd	62484-0020